Dichlorido{N′-[phen­yl(pyridin-2-yl-κN)methyl­idene]isonicotinohydrazide-κ(2) N′,O}zinc

The title compound, [ZnCl(2)(C(18)H(14)N(4)O)], crystallizes with two mol­ecules in the asymmetric unit, which differ in the tautomeric (neutral and zwitterionic) forms of the coordin­ating organic ligand. In both mol­ecules, the Zn(II) atom adopts a distorted square–pyramidal geometry by two N and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sy, Adama, Dieng, Moussa, Thiam, Ibrahima Elhadj, Gaye, Mohamed, Retailleau, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Metal-Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569202/
https://www.ncbi.nlm.nih.gov/pubmed/23424404
http://dx.doi.org/10.1107/S1600536813001281
Descripción
Sumario:The title compound, [ZnCl(2)(C(18)H(14)N(4)O)], crystallizes with two mol­ecules in the asymmetric unit, which differ in the tautomeric (neutral and zwitterionic) forms of the coordin­ating organic ligand. In both mol­ecules, the Zn(II) atom adopts a distorted square–pyramidal geometry by two N and one O atoms of the Schiff base ligand and two Cl atoms acting as monodentate chloride anions. The crystal packing is stabilized by N—H⋯N and N—H⋯Cl hydrogen bonds, forming a two-dimensional network parallel to the ac plane.

Ejemplares similares